BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-10-28 09:07
Net Asset Value(s)
English 4.0 KB
2020-10-27 08:11
Net Asset Value(s)
English 4.1 KB
2020-10-26 09:21
Net Asset Value(s)
English 4.0 KB
2020-10-23 08:52
Net Asset Value(s)
English 4.0 KB
2020-10-22 09:11
Net Asset Value(s)
English 4.0 KB
2020-10-21 11:05
Net Asset Value(s)
English 4.0 KB
2020-10-20 09:58
Net Asset Value(s)
English 4.0 KB
2020-10-19 10:39
Net Asset Value(s)
English 4.0 KB
2020-10-16 08:17
Net Asset Value(s)
English 4.1 KB
2020-10-15 08:46
Net Asset Value(s)
English 4.1 KB
2020-10-14 16:48
Net Asset Value(s)
English 4.0 KB
2020-10-13 09:45
Net Asset Value(s)
English 4.1 KB
2020-10-12 08:10
Net Asset Value(s)
English 4.1 KB
2020-10-09 13:10
Net Asset Value(s)
English 4.0 KB
2020-10-08 10:02
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

SanBio Company Limited Logo
Develops regenerative cell-based therapies for neurological disorders.
Japan
4592
SANGAMO THERAPEUTICS, INC Logo
A clinical-stage genomic medicine company developing therapies for severe diseases.
United States of America
SGMO
S.Biomedics Co., Ltd. Logo
Researches and develops stem cell-based therapies for regenerative medicine.
South Korea
304360
SCANCELL HOLDINGS PLC Logo
A clinical-stage company developing novel immunotherapies for the treatment of cancer.
United Kingdom
SCLP
Scandion Oncology A/S Logo
A biotech company under liquidation that developed cancer drug resistance therapies.
Denmark
SCOL
Scanway Spolka Akcyjna Logo
Develops optical observation and machine vision systems for space and industry.
Poland
SCW
Scholar Rock Holding Corp Logo
Develops therapies for serious diseases by targeting latent protein growth factors.
United States of America
SRRK
Schrodinger, Inc. Logo
A physics-based platform accelerating molecule discovery for therapeutics and materials.
United States of America
SDGR
Develops medical hemostatic agents and AI-driven digital healthcare solutions.
South Korea
246960
Scope Fluidics S.A. Logo
Biotechnology firm that incubates and sells microfluidic diagnostic projects.
Poland
SCP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.